PuSH - Publikationsserver des Helmholtz Zentrums München


114 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
Luteijn, R.D.* et al.: Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J. Immunol. 193, 1578-1589 (2014)
Rabenstein, H.* et al.: Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. J. Immunol. 192, 3507-3517 (2014)
Mayer, M.C.* et al.: Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J. Immunol. 191, 3594-3604 (2013)
Perera, N.C. et al.: NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity. J. Immunol. 191, 2700-2707 (2013)
Santner-Nanan, B.* et al.: Fetal-maternal alignment of regulatory T cells correlates with IL-10 and bcl-2 upregulation in pregnancy. J. Immunol. 191, 145-153 (2013)
Siegfried, A.* et al.: IFIT2 is an effector protein of type 1 IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock. J. Immunol. 191, 3913-3921 (2013)
Zhou, Q.H.* et al.: miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J. Immunol. 190, 6579-6588 (2013)
Boettcher, S.* et al.: Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J. Immunol. 188, 5824-5828 (2012)
Chu, Y.* et al.: A20 and CYLD do not share significant overlapping functions during B cell development and activation. J. Immunol. 189, 4437-4443 (2012)
Haneklaus, M.* et al.: Cutting edge: MiR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J. Immunol. 189, 3795-3799 (2012)
Panzer, M.* et al.: Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. J. Immunol. 188, 615-623 (2012)
Prinz, P.U. et al.: High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention. J. Immunol. 188, 5990-6000 (2012)
Schendel, D.J. ; Wilde, S. ; Leisegang, M.* & Uckert, W.*: Response to comment on "Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition". J. Immunol. 189, 3787-3788 (2012)
Wilde, S. et al.: Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition. J. Immunol. 189, 598-605 (2012)
Horst, D.* et al.: EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP. J. Immunol. 186, 3594-3605 (2011)
Kastenmüller, W.* et al.: Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J. Immunol. 187, 3186-3197 (2011)
Loschko, J.* et al.: Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity. J. Immunol. 186, 6718-6725 (2011)
Ortner, D.* et al.: The adaptor protein Bam32 in human dendritic cells participates in the regulation of MHC class I-induced CD8+ T cell activation. J. Immunol. 187, 3972-3978 (2011)
Burgler, S.* et al.: RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter. J. Immunol. 184, 6161-6169 (2010)